Preclinical Pharmacology of FMPD [6-Fluoro-10-[3-(2-methoxyethyl)-4-methyl-piperazin-1-yl]-2-methyl-4 H-3-thia-4,9-diaza-benzo[f]azulene]: A Potential Novel Antipsychotic with Lower Histamine H1 Receptor Affinity Than Olanzapine
Year: 2005
Type: article
Authors: Kurt Rasmussen, Mark J. Benvenga, Frank P. Bymaster, David O. Calligaro, Ilene R. Cohen, Julie F. Falcone, Susan K. Hemrick-Luecke, Fionna M. Martin, Nicholas A. Moore, Laura K. Nisenbaum, John M. Schaus, Sarah J. Sundquist, David E. Tupper, Todd R. Wiernicki, David L. Nelson
Institution: Eli Lilly (United States)
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2122332152